Status:
COMPLETED
Magnesium Sulfate During the Postpartum in Women With Severe Preeclampsia
Lead Sponsor:
Complejo Hospitalario Dr. Arnulfo Arias Madrid
Conditions:
Post Partum Severe Preeclampsia
Eligibility:
FEMALE
14-44 years
Phase:
PHASE2
PHASE3
Brief Summary
There is no evidence that patients receiving magnesium sulfate before birth are required to maintain the drug for 24 hours. Therefore the investigators will have a randomized clinical study in patient...
Detailed Description
The final treatment known for pre-eclampsia and eclampsia is the termination of pregnancy. However to prevent eclampsia in patients with severe pre-eclampsia has been demonstrated the effectiveness of...
Eligibility Criteria
Inclusion
- Severe preeclampsia or severe preeclampsia aggregated to chronic hypertension with \> 24 weeks of gestation treated with 4-6 grams of magnesium sulfate for impregnation with a minimum of 8 hours continuous of magnesium sulfate before delivery
- The study begins to terminate pregnancy
Exclusion
- HELLP syndrome
- Eclampsia
- Renal insufficiency
- Diabetes mellitus
- Disease of collagen
- Heart disease
Key Trial Info
Start Date :
December 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
1114 Patients enrolled
Trial Details
Trial ID
NCT02307201
Start Date
December 1 2014
End Date
December 1 2015
Last Update
February 1 2017
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Materno Infantil san Lorezo de las Minas
Santo Domingo, Santo Domingo Province, Dominican Republic
2
Hospital Universitario Maternidad Nuestra señoa de Alta Gracia
Santo Domingo, Santo Domingo Province, Dominican Republic
3
Hospital Teodoro Maldonado De Guayaquil
Guayaquil, Ecuador
4
Hospital Primero de Mayo
San Salvador, El Salvador